Cancer-Translational Nanotechnology Training Program (Cancer-TNT)
癌症转化纳米技术培训计划(Cancer-TNT)
基本信息
- 批准号:8934256
- 负责人:
- 金额:$ 22.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2020-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The proposed postdoctoral training program, Cancer-Translational Nanotechnology Training (Cancer-TNT) Program, is a diverse and synergistic 3-year training program bringing together 25 faculty and 9 Departments from three schools to train the next generation of interdisciplinary leaders who will pursue challenges in cancer research and clinical translation. Cancer nanotechnology is a rapidly growing field that requires close interactions of researchers from disparate fields of science, such as chemistry, materials science, cancer biology, and medicine. During the proposed 5-year cycle, we will recruit a total of 12 postdoctoral trainees to provide them with education and cross-disciplinary training to develop interdisciplinary researchers in cancer nanotechnology translation. Eight (8) trainees will complete training during the 5-year cycle. Our trainees' skill sets will bridge multiple disciplines such as chemistry, molecular biology, bioengineering, molecular imaging, nanoengineering, and clinical cancer medicine. Trainees will be able to advance cancer research, diagnosis, and management. The Molecular Imaging Program at Stanford (MIPS) from the medicine side, with the Departments of Chemistry, Materials Science and Engineering from the engineering side, will provide a solid foundation for our program. The Stanford environment also leads a productive Center for Cancer Nanotechnology Excellence (CCNE-T), an NCI Designated Comprehensive Cancer Center, an In Vivo Cellular and Molecular Imaging Center (ICMIC @ Stanford), the highly effective interdisciplinary Bio-X program, facilities for Nanofabrication and Nanocharacterization, as well as Nanoinformatics capabilities, the Canary Center for Cancer Early Detection, and a Physical Sciences Oncology Center (PSOC), in which several of our mentors have leading roles. Through these activities, we have already been successfully training the next generation of cancer nanotechnologists and we are excited by the possibility to formalize and expand training activities through the Cancer-TNT. Our program includes a diverse group of faculty mentors representing five program areas. Through this mentor group, we are able to bring together formal courses in cancer biology, cancer immunology, molecular imaging, molecular pharmacology, and gene therapy, nanomedicine, micro/nanofabrication, biochips, electrical engineering, and materials science; hands-on training activities in Nanocharacterization; and a clinical component including Stanford Oncology Clinical Lecture Series. The Cancer-TNT fellows will be recruited into a 3-year program to complete coursework and research with two complementary mentors. Trainees will prepare a mock grant proposal in their second year to help them gain experience and confidence in the grant application process. A Training Committee will oversee trainee progress, with an Advisory Committee monitoring the entire program. Stanford University, with support from the NCI, is poised to be a major training center for the rapidly growing field of cancer nanotechnology.
描述(由申请人提供):拟议的博士后培训计划,癌症转化纳米技术培训(癌症-TNT)计划,是一个多样化和协同的3年培训计划,汇集了来自三所学校的25名教师和9个部门,以培养下一代跨学科领导者,他们将追求癌症研究和临床翻译的挑战。癌症纳米技术是一个快速发展的领域,需要来自不同科学领域的研究人员的密切互动,如化学,材料科学,癌症生物学和医学。在拟议的5年周期内,我们将招募共12名博士后学员,为他们提供教育和跨学科培训,以培养癌症纳米技术翻译的跨学科研究人员。八(8)名受训人员将在五年周期内完成培训。我们的学员的技能将跨越多个学科,如化学,分子生物学,生物工程,分子成像,纳米工程和临床癌症医学。学员将能够推进癌症研究,诊断和管理。斯坦福大学(MIPS)的分子成像项目将为我们的项目提供坚实的基础。斯坦福大学的环境还导致了一个生产中心的癌症纳米技术卓越(CCNE-T),NCI指定的综合癌症中心,在体内细胞和分子成像中心(ICMIC @斯坦福大学),高效的跨学科Bio-X计划,纳米结构和纳米表征设施,以及纳米信息学能力,金丝雀癌症早期检测中心,和物理科学肿瘤中心(PSOC),其中我们的几位导师担任领导角色。通过这些活动,我们已经成功地培训了下一代癌症纳米技术专家,我们对通过Cancer-TNT正式化和扩大培训活动的可能性感到兴奋。我们的计划包括代表五个计划领域的教师导师的多元化群体。通过这个导师小组,我们能够汇集癌症生物学,癌症免疫学,分子成像,分子药理学和基因治疗,纳米医学,微/纳米纤维,生物芯片,电气工程和材料科学的正式课程;纳米表征的实践培训活动;和临床部分,包括斯坦福大学肿瘤学临床讲座系列。癌症TNT研究员将被招募到一个为期3年的计划,完成课程和研究与两个互补的导师。学员将在第二年准备一份模拟赠款提案,以帮助他们获得赠款申请过程中的经验和信心。培训委员会将监督学员的进展,咨询委员会将监督整个计划。斯坦福大学在NCI的支持下,准备成为快速发展的癌症纳米技术领域的主要培训中心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DEAN W FELSHER其他文献
DEAN W FELSHER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DEAN W FELSHER', 18)}}的其他基金
Molecular Mechanisms by which Statins Prevent and Reverse Hepatocellular Carcinoma
他汀类药物预防和逆转肝细胞癌的分子机制
- 批准号:
10856787 - 财政年份:2023
- 资助金额:
$ 22.7万 - 项目类别:
Targeting the MYC Pathway for the Treatment of Cancer
靶向 MYC 通路治疗癌症
- 批准号:
10463750 - 财政年份:2020
- 资助金额:
$ 22.7万 - 项目类别:
Targeting the MYC Pathway for the Treatment of Cancer
靶向 MYC 通路治疗癌症
- 批准号:
10693915 - 财政年份:2020
- 资助金额:
$ 22.7万 - 项目类别:
Targeting the MYC Pathway for the Treatment of Cancer
靶向 MYC 通路治疗癌症
- 批准号:
10256047 - 财政年份:2020
- 资助金额:
$ 22.7万 - 项目类别:
Targeting the MYC Pathway for the Treatment of Cancer
靶向 MYC 通路治疗癌症
- 批准号:
10053533 - 财政年份:2020
- 资助金额:
$ 22.7万 - 项目类别:
(PQ7)Multi-scale Analysis of Tumor Microenvironment Heterogeneity
(PQ7)肿瘤微环境异质性多尺度分析
- 批准号:
9378269 - 财政年份:2017
- 资助金额:
$ 22.7万 - 项目类别:
Cancer-Translational Nanotechnology Training Program (Cancer-TNT)
癌症转化纳米技术培训计划(Cancer-TNT)
- 批准号:
9443842 - 财政年份:2015
- 资助金额:
$ 22.7万 - 项目类别:
Cancer-Translational Nanotechnology Training Program (Cancer-TNT)
癌症转化纳米技术培训计划(Cancer-TNT)
- 批准号:
9321153 - 财政年份:2015
- 资助金额:
$ 22.7万 - 项目类别:
Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging
通过质谱成像预测癌症的代谢特征
- 批准号:
8673796 - 财政年份:2014
- 资助金额:
$ 22.7万 - 项目类别:
Modeling and Predicting Therapeutic Resistance of Cancer
癌症治疗耐药性的建模和预测
- 批准号:
8766569 - 财政年份:2014
- 资助金额:
$ 22.7万 - 项目类别:
相似海外基金
Evaluating the impact of spreading depolarisations, post stroke, in the awake brain using graphene-enabled nanotechnology.
使用石墨烯纳米技术评估中风后清醒大脑中扩散去极化的影响。
- 批准号:
MR/Y014545/1 - 财政年份:2024
- 资助金额:
$ 22.7万 - 项目类别:
Research Grant
Conference: The 17th US-Korea Forum on Nanotechnology: Next-Generation Semiconductors and the Environmental Implications of Semiconductor Manufacturing
会议:第十七届美韩纳米技术论坛:下一代半导体和半导体制造的环境影响
- 批准号:
2309500 - 财政年份:2023
- 资助金额:
$ 22.7万 - 项目类别:
Standard Grant
New nanotechnology for non-invasive deep lung-activatable antimicrobial photodynamic therapy of hospital-associated pneumonia
新型纳米技术用于非侵入性深部肺激活抗菌光动力治疗医院相关性肺炎
- 批准号:
478523 - 财政年份:2023
- 资助金额:
$ 22.7万 - 项目类别:
Operating Grants
Defining single-channel paracellular (tight junction) conductances using nanotechnology
使用纳米技术定义单通道旁细胞(紧密连接)电导
- 批准号:
10593421 - 财政年份:2023
- 资助金额:
$ 22.7万 - 项目类别:
2023 RNA Nanotechnology Gordon Research Conference and Seminar
2023年RNA纳米技术戈登研究会议暨研讨会
- 批准号:
10598881 - 财政年份:2023
- 资助金额:
$ 22.7万 - 项目类别:
Fabrication of Gold Nanorings-based Functional Nanostructures by virtue of DNA Nanotechnology
利用 DNA 纳米技术制备金纳米环基功能纳米结构
- 批准号:
22KF0356 - 财政年份:2023
- 资助金额:
$ 22.7万 - 项目类别:
Grant-in-Aid for JSPS Fellows
NSF Postdoctoral Fellowship in Biology: Leveraging Biocoronas for Enhanced Agricultural Nanotechnology
NSF 生物学博士后奖学金:利用生物电晕增强农业纳米技术
- 批准号:
2305663 - 财政年份:2023
- 资助金额:
$ 22.7万 - 项目类别:
Fellowship Award
2023 Quadrennial Review of the National Nanotechnology Initiative (NNI)
2023 年国家纳米技术计划 (NNI) 四年一度审查
- 批准号:
2329910 - 财政年份:2023
- 资助金额:
$ 22.7万 - 项目类别:
Standard Grant
2023 Cancer Nanotechnology Gordon Research Conference and Gordon Research Seminar
2023癌症纳米技术戈登研究大会暨戈登研究研讨会
- 批准号:
10609291 - 财政年份:2023
- 资助金额:
$ 22.7万 - 项目类别:
Project LIPICARE - Combining nanotechnology, gene editing and CAR-T to create a 'one-shot' cure for cancer
LIPICARE 项目 - 结合纳米技术、基因编辑和 CAR-T 创造一种“一次性”治愈癌症的方法
- 批准号:
10034471 - 财政年份:2023
- 资助金额:
$ 22.7万 - 项目类别:
Collaborative R&D